Soros wins with ViroPharma
Today’s top gainer is biotechnology company ViroPharma Inc (NASDAQ:VPHM). The stock surprisingly shot up +25.50% to $49.42. According to Bloomberg, this is the result of health company Shire Plc (NYSE:SHP) reaching an agreement to buy ViroPharma for $4.2 billion. Billionaire George Soros acquired 50,000 shares (0.02% of his fund) for $26.29 each last quarter.